Hhyperbaric Chamber for the Treatment of Cancerous Tumors
The growing number of patients afflicted with various types of cancer-related complications across the nation is becoming a major health concern for the medical community in the United States.
Cancer is a serious affliction that can spread to all parts of the human body at a rapid pace and any lag in providing requisite treatment in the initial stages can have life-threatening repercussions for the affected patients.
Ongoing research programs have greatly helped medical experts find sustainable treatment solutions such as hyperbaric oxygen therapy that is known to help patients find relief from cancer-related health issues.
Cancer specialists are increasingly recommending the use of a hyperbaric chamber to patients battling cancerous tumors.
How Can A Hyperbaric Chamber Aid Cancer Patients?
In the early 1960s’, doctors introduced an alternative treatment method known as hyperbaric oxygen therapy (HBOT) to successfully provide relief to deep-sea divers struggling with symptoms of decompression sickness.
Subsequently, hyperbaric researchers discovered that HBOT can also be used to treat ailments such as non-healing diabetic wounds, burn injury, gas embolism, radiation injury, traumatic brain injury, and other debilitating conditions.
In the last decade, research studies conducted by hyperbaric experts revealed the efficacy of HBOT whilst treating cancer patients.
Hyperbaric Chamber For Cancer Relief:
During the process of HBOT, a cancer patient is placed in a pressurized compartment known as a hyperbaric chamber. Thereafter, the staff at the clinic administers the patient with pressurized unadulterated oxygen that is 1.2 to 3 times greater than normal atmospheric pressure for 60-90 minutes daily, three to five times a week.
The high-pressure environment inside the hyperbaric chamber instantly dissolves the pure oxygen into the body fluids of the patient and boosts the enriched plasma to all the cancer-affected parts that have low blood-oxygen levels. The enhanced surge of oxygen-rich blood flow within the body during hyperbaric therapy is known to significantly expedite the healing process in cancer patients.
The therapy can be extended depending upon the severity of the patients’ medical condition.
What Are The Main Factors That Cause Cancerous Tumors?
Three main factors aid the growth of cancerous tumors in individuals, namely:
Cancer patients are known to adapt HBOT to effectively counter these above-mentioned conditions.
HBOT For Countering Metastasis:
Metastasis is a condition that occurs due to the tumor-cell invasion of lymph vessels. This complication is known to be the primary cause of mammary tumors or breast cancer.
The pure oxygen introduced to the cancer patient inside a hyperbaric chamber is known to encourage a mesenchymal-to-epithelial transition (MET) in DMBA-induced mammary tumors. A stabilized MET level curbs the risk of malignancy in the cancerous tumor.
HBOT For Curbing Hypoxia:
Low levels of oxygen are known to be the primary cause of hypoxia in patients. Prolonged hypoxia encourages an increased proliferation of cancer-causing cells and eventually leads to the rapid development of cancerous tumors.
The oxygen-rich plasma that is propelled to the affected parts having lowered blood-oxygen levels during HBOT instantly aid in:
The proliferation of fibroblasts.
Removal of excess collagen.
These aspects curtail the development of cancer cells and aid recovery.
HBOT For Combating Angiogenesis:
Angiogenesis is largely responsible for the spread of cancer cells in the body.
Hyperbaric experts are known to have observed a notable reduction in the angiogenesis levels of cancer patients post regular HBOT.
Hyperbaric experts engaged in cancer research programs worldwide, firmly advocate the use of hyperbaric oxygen therapy as a secondary therapy alongside other conventional treatment methods, to treat patients ailing from varied types of cancers such as:
HBOT For Leukemia:
Surplus production of immature white blood cells leads to leukemia or blood cancer in individuals.
Patients using a hyperbaric chamber are known to have developed enhanced apoptosis, a process that curtails the spread of excess white blood cells.
HBOT For Head and Neck Cancer:
Clinical studies involving mice with head and neck carcinoma are known to have displayed reduced hypoxia levels post HBOT. The research teams have also recorded reduced levels of angiogenesis in these specimens.
HBOT For Colorectal Cancer:
Patients with colorectal cancer are known to have experienced a reduction in the tumor size after coupling SMA-pirarubicin with HBOT. This improvement in health has been primarily attributed to the sizeable reduction in liver metastases.
Heightened levels of necrosis have also been recorded in patients during experimental trials.
Leading cancer specialists are recommending using HBOT as an adjunctive treatment solution along with other standard cancer treatment options such as radiation therapy, chemotherapy, and photodynamic therapy.
The unadulterated oxygen-induced within a hyperbaric chamber is also known to aid cancer patients in their recovery from radiation wounds sustained during extended chemotherapy sessions.
A hyperbaric chamber is currently known to be a safe and viable device that is enabling patients to dream of living a cancer-free life.